BioGaia Logo

BioGaia

A healthcare and biotechnology company developing clinically proven probiotic products.

BIOG | ST

Overview

Corporate Details

ISIN(s):
SE0000470395 (+2 more)
LEI:
549300UBUJOY2L7TT361
Country:
Sweden
Address:
Box 3242, 103 64 Stockholm

Description

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2012-10-15 15:28
BioGaia’s probiotic safe and effective in premature infants
English 497.6 KB
2012-10-15 15:28
BioGaias probiotika hjälper för tidigt födda barn
Swedish 500.0 KB
2012-10-12 10:28
BioGaia tecknar exklusivt distributionsavtal för sina probiotiska droppar och t…
Swedish 441.5 KB
2012-10-12 10:28
BioGaia signs exclusive distribution agreement for its probiotic drops and tabl…
English 446.4 KB
2012-09-17 15:29
Lactobacillus reuteri Protectis shown to reduce colic in infants
English 454.2 KB
2012-09-17 15:29
Lactobacillus reuteri Protectis minskade kolik hos spädbarn
Swedish 463.5 KB
2012-09-07 10:59
BioGaias probiotika förhindrade nekrotiserande enterokolit hos för tidigt födda…
Swedish 472.9 KB
2012-09-07 10:59
BioGaia’s probiotic prevented necrotizing enterocolitis in high risk premature …
English 474.4 KB
2012-08-21 07:59 Swedish 848.0 KB
2012-08-21 07:59 English 870.0 KB
2012-06-13 08:30
BioGaia tecknar exklusivt avtal för sina probiotiska droppar och sin vätskeersä…
Swedish 444.3 KB
2012-06-13 08:30
BioGaia signs exclusive agreement for its probiotic drops and oral rehydration …
English 449.4 KB
2012-05-15 14:00
BioGaia tecknar exklusiva distributionsavtal för sina munhälsoprodukter i Tjeck…
Swedish 462.2 KB
2012-05-15 14:00
BioGaia signs exclusive distribution agreements for its oral health products in…
English 465.3 KB
2012-05-14 09:00
BioGaia initierar forskningsstudie med typ 2-diabetiker
Swedish 443.7 KB

Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioGaia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioGaia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-08 Barbro Fridén Other Buy 188 19,627.20 SEK
2024-09-13 Linda Hägglund Other Sell 2,000 233,800.00 SEK
2024-09-12 Linda Hägglund Other Sell 994 115,502.80 SEK
2024-09-12 Linda Hägglund Other Sell 6 697.80 SEK
2024-06-10 Outi Armstrong Other Buy 1,000 125,400.00 SEK
2023-08-02 Anthon Jahreskog Other Buy 481 51,515.10 SEK
2023-08-02 Anthon Jahreskog Other Buy 169 18,083.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.